How to handle non-conformities and get back on track

Dr Will Brambley
Turning blocks from crosses to ticks

In the highly regulated world of regulatory affairs, technical documentation serves as a cornerstone for ensuring product compliance, safety, and efficacy. Yet even the most meticulously prepared documents can face non-conformities during review.

A Mantra Systems x Cyber Alchemy Perspective - Episode 2

This article is published in partnership with Cyber Alchemy. Mantra Systems specialises in medical device regulatory strategy and technical documentation for UK and EU MDR/IVDR pathways. Cyber Alchemy focuses on cybersecurity, helping teams develop and evidence security for software-enabled and connected medical devices. Together, we're producing a practical series for MedTech teams: what to build, what to defer, and how to avoid avoidable rework when moving between UK, NHS procurement, and EU routes.

What is a non-conformity and why do they happen?

In the context of the EU Medical Device Regulation (EU MDR), a non-conformance refers to a situation where a medical device, process, or quality management system does not meet the requirements outlined in the regulation (EU MDR, ISO 13485) and the organisation’s aligned procedures. Non-conformities can occur during numerous stages of the medical device lifecycle, including design, manufacturing, post-market surveillance, or quality management, and may include:

  • Clinical data gaps
  • Inappropriate equivalence claims
  • Incomplete or inaccurate document content
  • Use of outdated or superseded regulations or standards

Non-conformities can significantly disrupt the approval process, leading to extended review timelines, increased costs, and further revision cycles. Since Notified Bodies cannot accept a technical file with unresolved non-conformities, correcting them is critical for market access.

In my experience many non-conformities, particularly those relating to clinical evaluation or risk management, arise because the technical file is disjointed and does not tell a coherent story. The technical file is not simply a library of information relating to a device. It should guide a reviewer through the life of the device from conceptualisation right through to pre-clinical and clinical testing of a device, while clearly demonstrating safety, performance and an acceptable benefit-risk profile.

Companion perspective (Cyber Alchemy)

This article examines common regulatory non‑conformities in medical device submissions. A companion article from Cyber Alchemy addresses cybersecurity‑specific non‑conformities. Together, these articles provide a comprehensive approach to aligning your strategy for managing non‑conformities.

Common non-conformities for SaMDs

Quality Management

  • Lack of evidence that existing procedures have been followed
  • Lack of design controls for software changes
  • Poor documentation of suppliers and Software of Unknown Provenance (SOUP)
  • Ineffective Corrective and Preventive Action (CAPA) system

Clinical evaluation and evidence gaps

Software lifecycle documentation which falls short of the standards of IEC 62304

  • Missing or incomplete software development plan
  • Poor traceability between user requirements, design, verification and validation
  • Lack of detail in the documentation of software architecture
  • Insufficient verification & validation evidence
  • Poor SOUP version control

Risk Management

  • Risk files not updated throughout device lifecycle
  • Poor linkage between hazards, risks, controls, and verification
  • Missing software-specific risks (e.g., cybersecurity, data corruption, incorrect outputs)
  • Lack of a quantitative benefit-risk analysis

Issues with Annex II/III documentation

  • Unclear or vague intended purpose statement
  • Unclear post-market surveillance plan or procedure

How to address non-conformities

The first step to addressing non-conformities is to have a clear discussion with your Notified Body about the non-conformities that they have raised. Notified Bodies are obligated to communicate non-conformities to you, but there is no legislative requirement for them to provide a video-call or structured dialogue discussion, so it’s worth knowing whether your Notified Body offers this before starting the assessment process.

During a discussion about non-conformities, your Notified Body can only offer clarification, as opposed to recommendations or guidance about how to fix them. They can give you more detail as to why an issue has been flagged, but they can’t tell you exactly how to fix them.

Once you have the non-conformity report from the Notified Body, I always recommend creating your own summary list of non-conformities that will need to be addressed. Formats for these reports vary between Notified Bodies and can be confusing sometimes.

With your summary list, you can group non-conformities together and identify solutions which may address multiple issues. You can also clearly assign each non-conformity a solution and a team member to action it.

Notified Bodies will give you a timeline for response and resubmission of your documents. Where you feel that you require more time to adequately address deficiencies, you should ask for an extension to the timeline early on.

Free 30-minute review call

If you’re still unclear about how to address non‑conformities, engaging expert support can be the most effective way to navigate the review process and achieve your UKCA or CE mark. When deficiencies span both regulatory and cybersecurity domains, no single perspective is enough.

That’s why Mantra Systems and Cyber Alchemy are offering a free 30-minute joint review, so you get a complete picture of your technical file and cybersecurity gaps, and a clear, actionable recovery plan in one conversation.

Book your free 30-minute review

Episode 1 from Mantra Systems
Where to Launch First? A MedTech Founder's Regulatory Roadmap to the EU, UK and US
Episode 1 from Cyber Alchemy
EU MDR & NHS DTAC Cybersecurity Requirements for UK Market Entry
Episode 2 from Mantra Systems
How to handle non-conformities and get back on track
Episode 2 from Cyber Alchemy
EU MDR, FDA 510(k) and DTAC Cybersecurity Nonconformities: How to Recover

Related articles

  1. Stopping the collapse of dominoes by placing finger on a red risk dominoe.

    Understanding Risk Management for SaMD

    Practical guidance on SaMD risk management under EU MDR — from component-level hazard identification to Post-Market Surveillance and ISO 14971 traceability.

    Megan Allen Megan Allen Regulatory Medical Writer
  2. A concerned medical device software developer considering the complexities of regulatory compliance

    Avoiding slow SaMD approval: A guide to faster market entry

    Most SaMD developers make avoidable mistakes that add months to approval. Here's what they are and how to sidestep them.

    Paul Hercock Paul Hercock CEO & Founder
  3. US and EU flag signposts pointing in different directions

    Top 5 mistakes US manufacturers make when entering the EU market

    Expanding into the EU market? Discover the five most common regulatory mistakes U.S. medical device manufacturers make — and how to avoid them.

    Aastha Kothari Aastha Kothari Regulatory Medical Writer
  4. A process flow leading to a cybersecurity evidence pack

    EU MDR, FDA 510(k) and DTAC Cybersecurity Nonconformities: How to Recover

    This guest article shows how these cybersecurity nonconformities happen, what recovery actually involves, and what to build so you don't go back.

    Neil Richardson Neil Richardson Co-Founder of Cyber Alchemy
  5. US and EU flags on poles alongside each other.

    Clinical Evidence under EU MDR: Leveraging FDA Clinical Data to Streamline EU MDR Compliance

    FDA clearance alone is not sufficient for European market access - a theme we explore futher in this article and the accompanying webinar.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  6. 3 people in an office in front of a whiteboard with the words 'Medical Device Market Entry Strategy' written above a world map.

    EU MDR & NHS DTAC Cybersecurity Requirements for UK Market Entry

    This guest article shows you how to build cybersecurity evidence for the EU MDR and NHS DTAC.

    Luke Hill Luke Hill Co-Founder of Cyber Alchemy
  7. An illustration showing a GPS-driven navigation route superimposed upon someone using a laptop.

    Where to Launch First? A MedTech Founder's Regulatory Roadmap to the EU, UK and US

    All three markets operate under different regulatory systems and place different demands on manufacturers.

    Ronghe Xu Ronghe Xu Regulatory Medical Writer & Strategic BD Lead China
  8. A woman uses an inhaler.

    Navigating EU MDR Article 117: A Practical Guide to Drug-Device Combination Product Submissions

    Implementation of the EU MDR 2017/745 has brought significant changes.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  9. Collage art showing a pair of binoculars, an analogy for surveillance.

    How EU MDR Post Market Surveillance differs from FDA post-market expectations

    EU MDR and FDA post-market obligations aren't as similar as you might think. Here's what manufacturers need to know.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  10. An arrow arcs from the US over to Europe.

    How EU device classification differs from the US - Are you prepared?

    Did you know an FDA Class II medical device could be immediately considered as a high-risk Class III device under European Union regulations?

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  11. A magnifying glass inspecting a number of wooden cubes with question marks upon them laid upon a blue table. The wooden cube under the magnifying glass has a lightbulb painted on it.

    Fixing the MDR and IVDR? The Commission’s Proposed Amendments and What They Mean for Manufacturers

    Exploring the key elements of this proposal.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  12. Two arms point at a sign and hold a question mark, in an abstract pop-art style.

    Regulatory Reset? The EU’s Proposed Changes to MDR and IVDR Explained

    Changes published in December 2025 aim to streamline EU medical device and in vitro diagnostics. We explain who is impacted and how.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  13. A pair of glasses rests on an eye test chart.

    Did You Know Your Glasses Were a Medical Device? A Regulatory Guide for Manufacturers

    The importance of correct classification and our recommended path to avoid common ophthalmic device 'gotchas'.

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  14. A precariously balanced pile of ping-pong balls and wooden bars.

    The Shift from MDD to MDR: Key Differences in Demonstrating Equivalence

    This transition has demanded that device safety must be demonstrated with more evidence. We offer tips for winning equivalence claims.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  15. A pen and notepad, resting on a laptop.

    Periodic Safety Update Report: Requirements under EU MDR

    Post-Market Surveillance has become more stringent. We help you to understand what manufacturers need to consider.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  16. An EU flag on a pole flies between two US flags against a blue sky.

    Webinar: From USA to Europe - Accelerating Your Path to the Medical Device Market

    We showed you how to quickly transform your U.S. regulatory work into a compliant EU MDR submission.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  17. A poster frame for our Clinical Evaluation video series featuring Paul Hercock.

    Guide to Clinical Evaluation: Common Pitfalls & Useful Resources

    Part 5 - In the final video from this series, we explore five major pitfalls that often derail clinical evaluations.

    Paul Hercock Paul Hercock CEO & Founder
  18. A US-style 'changes ahead' warning road sign.

    Device Modifications: When a Simple Change Becomes a Regulatory Nightmare

    As regulatory consultants we understand how minor modifications to a device can often cause disproportionate disruption.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  19. Webinar announcement poster.

    Webinar: Regulatory & Cybersecurity Essentials for medical device software and AI-enabled devices

    Our webinar with Cyber Alchemy addressed bringing AI-enabled medical devices to market with both the right regulatory and cybersecurity foundations.

    Shen May Khoo Shen May Khoo Regulatory Project Lead
  20. A simple jigsaw with iconography representing growth printed on it.

    Leveraging Post-Market Surveillance Data for Continuous Improvement

    PMS isn’t just about compliance, it’s an opportunity for improvement, enhance patient safety & innovate.

    Shen May Khoo Shen May Khoo Regulatory Project Lead
  21. A poster frame for our Clinical Evaluation video series featuring Dr. W. Brambley.

    Guide to Clinical Evaluation: CEP Strategy & CER Structure

    Part 4 - We explore how these guide reviewers through the evidence that supports safey, performance, and conformity.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  22. A checklist being ticket-off in pen.

    The Critical Role of Pre-Submission Reviews in EU MDR Clinical Evaluations

    Ensuring your CER is robust and aligned with current standards is critical. How much Clinical Evidence is enough?

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  23. A poster frame for our Clinical Evaluation video series featuring Dr. W. Brambley.

    Guide to Clinical Evaluation: The State-of-the-Art (SOTA) Literature Review

    Part 3 - This is core of a sucessful submission. Will demystifies the process and explains how it supports clinical evaluation.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  24. An orange tabletop with wooden question mark blocks laid upon it.

    Regulatory Update: EU Borderline & Classification Manual for medical devices v4

    New examples sharpen the distinction between medical devices and other product categories, such as pharmacologically active substances and aesthetic-only products.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  25. A poster frame for our Clinical Evaluation video series featuring Dr. P. Boxall.

    Guide to Clinical Evaluation: Clinical Evaluation in Context

    Part 2 - A clinical evaluation demonstrates that a device is safe and effective, but achieving this requires more than simply compiling studies.

    Dr Peter Boxall Dr Peter Boxall Lead Medical Writer
  26. A poster frame for our Clinical Evaluation video series featuring Dr. P. Hercock.

    Introducing Our Guide to Clinical Evaluation Video Series: Building Strong Submissions Under MDR

    First of a five-part series of step-by-step guides.

    Paul Hercock Paul Hercock CEO & Founder
  27. A digitally generated image of a checklist being completed on a laptop computer.

    Maximise your success with our Clinical Evaluation pre-submission check

    We’re announcing the launch of a new service designed to help you with CER, CEP, and SOTA documentation – ensuring that documents meet Notified Body expectations and accelerating your route to market.

    Shona Richardson PhD Shona Richardson PhD Regulatory Project Lead
  28. Webinar announcement poster.

    Regulatory Strategy Essentials for Digital Health: Key Takeaways from Our Webinar

    We showed how to accelerate your runway to market through actionable steps that will shave months off your route to regulatory approval.

    Dr Peter Boxall Dr Peter Boxall Lead Medical Writer
  29. A laptop projects an alert to a user sitting at a desk.

    Vigilance & Incident Reporting: Everything You Need to Know

    Navigating the Complexities and Ensuring Patient Safety in Medical Devices.

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  30. An EU and US flag lying together.

    Achieving EU MDR approval when you are cleared under FDA

    Our guide to navigating the transition from FDA clearance to EU market access.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  31. Some binocular-hand eyes as an analogy for surveillance.

    Post-Market Surveillance (PMS): Understanding PMCF & Vigilance under the EU MDR

    These serve distinct purposes and have different methodologies under the MDR framework. We breakdown each.

    Ronghe Xu Ronghe Xu Regulatory Medical Writer & Strategic BD Lead China
  32. A vision testing device.

    Implementing Master UDI-DIs: Key Insights from MDCG 2025-7

    Grouping devices with design similarities under a common Eudamed ID could unify them under a single master UDI-DI

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  33. A person studying at a desk with pad and paper.

    In the World of Regulatory Writing: 5 Lessons Learned

    Let’s break down some key lessons learned from the writing process and share practical tips to navigate them with clarity (and your sanity) intact.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  34. Poster frame for video with Sue Kemp.

    Do you have the clinical evidence you need to support regulatory approval?

    Sue Kemp makes the case for implementing clinical strategy from day one.

    Paul Hercock Paul Hercock CEO & Founder
  35. An actual conventional UK passport.

    A New Era for NHS Innovation: ‘Innovator Passports’

    A digital fast-track system aims to transform how new medical technologies are adopted across the NHS, cutting red tape and accelerating access to medtech.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  36. LinkedIn live webinar poster.

    From Idea to Approval: Get MDR Ready With Our LinkedIn Live

    An upcoming LinkedIn Live session with Dr. Zhong Wei Khor tailored specifically for healthtech founders.

    Paul Hercock Paul Hercock CEO & Founder
  37. A man crosses a high-wire across a forest.

    The Never-Ending Document Updates: Navigating Changing Regulations

    Just because you’ve submitted a document, it doesn’t mean the work is done. Clinical Evaluation Reports, Risk Management Files or PMS plans will all need updating.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  38. A judges gavel sat infront of a Union Jack flag.

    UK Medical Device Regulations Set for Major 2026 Update

    The UK government is preparing to introduce a second major update to the regulatory framework for medical devices, with new pre-market requirements expected to come into effect in 2026.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  39. Video poster frame for Episode 3 of our series.

    Clinical Evaluation Masterclass: It is not clear that any systematic search methods were used for the literature review – Episode 3

    Addressing non-conformities isn’t just about avoiding negative outcomes; it’s about building a robust, evidence-based foundation.

    Paul Hercock Paul Hercock CEO & Founder
  40. A woman writes notes at her desk.

    Regulatory Writing Deadlines: The Pressure to Get It Right the First Time

    Anyone who’s worked in the medical device industry knows that regulatory deadlines aren’t just part of the process—they define it.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  41. Medical phone software being used to communicate with a monitor placed on a mans skin.

    IEC 62366-1:2015 Demystified – Essential Usability Testing for Medical Devices

    What should be included in a Usability Engineering File? What steps do you need to take to ensure compliance and meet standards?

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  42. Video poster frame for Episode 2 of our ongoing series.

    Clinical Evaluation Masterclass: Appraisal of literature sources has not been conducted properly - Episode 2

    Our ongoing series covers one of the most frequent reasons for CER rejection: a poor appraisal of literature sources.

    Paul Hercock Paul Hercock CEO & Founder
  43. A lone figure navigates a rocky coastline.

    Navigating CAPA Terminology: Key Terms for Medical Device Professionals

    We define and explain the language required to work within a Quality Management System (QMS).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  44. Video poster frame for Episode 1 of our new series.

    Clinical Evaluation Masterclass: Overcoming Non-conformities - Episode 1

    In this series, we work step-by-step through common Non-Conformities to ensure you are always ahead of possible challenges on the way to MDR approval.

    Paul Hercock Paul Hercock CEO & Founder
  45. A man carefully steps across a cliff-face. An analogy for assessing risk.

    Top 5 Common Pitfalls to Avoid During Risk Assessment

    Learn how to sidestep costly mistakes which manufacturers commonly make. From hazard ID to post-market surveillance, we help you improve safety and speed up approvals.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  46. A label maker printing bar-code labels.

    Labelling 101: A Comprehensive Overview for Medical Device Manufacturers

    Labelling and packaging are critical elements to ensuring safety, compliance, and ease of use.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  47. An illustration of a brain-shaped object on an abstract background.

    European Commission Guidelines on Prohibited Artificial Intelligence Practices

    Summary of the 8 AI practices prohibited by the EU 2024/1689 artificial intelligence (AI) Act.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  48. A compass being used to navigate across mountainous countryside.

    Navigating Non-Conformities in Technical Documentation

    We explore how to manage non-conformities effectively and implement Corrective and Preventive Actions (CAPAs).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  49. A photograph of a literal maze that we're using as a clever metaphor.

    Mastering the EU MDR: Essential Steps for Compliance-Ready Docs

    If you're uncertain about the readiness of your EU MDR documentation, this article provides an overview of the essential steps to ensure you’re on track.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  50. An illustration showing scientists at work.

    A Guide to Electronic Instructions for Use (eIFU)

    Electronic Instructions for Use (eIFUs) are set to revolutionise how medical device instructions are delivered. We explore what this means for you.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  51. Two helicopters look as if they are about to collide: An analogy for risk.

    Navigating Risk Management Requirements under the EU MDR

    This is a cornerstone of EU MDR 2017/745, requiring a continuous, well-documented approach. We unpack key requirements and provide actionable strategies.

    Dr Peter Boxall Dr Peter Boxall Lead Medical Writer
  52. A doctor operates a tablet computer.

    Beyond the Acronyms: Understanding SaMD and SiMD

    As software advancements continue, the line between traditional hardware-centric medical devices and software-driven solutions becomes increasingly blurred.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  53. A team of profesional-looking people sit around a table, congratulating themselves.

    Extending the Validity of your IVDD Certificates – Key Dates

    The EU and the MHRA have extended the validity of IVDD certificates, allowing you more time to transition to the IVDR. We explain what this means for manufacturers.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  54. A team of profesional-looking people sit around a table, congratulating themselves.

    GSPR 1: A New Era of Performance with Safety at the Core

    This regulation emphasizes risk management, durable design & biocompatibility to ensure medical devices are safe and effective. GSPR 1 protects users while driving innovation in medical technology.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  55. Cybersecurity Vulnerabilities in Medical Devices: FDA Alerts on Contec and Epsimed Monitors

    Patients can be exposed to risks when devices are online. We explore implications for EU MDR/IVDR cybersecurity requirements, including MDCG guidance

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  56. A futuristic-looking factory full of labelled cardboard boxes.

    Decoding UDI: Your Ultimate Guide to Smarter Medical Device Labelling

    The Unique Device Identifier (UDI) ensures medical device traceability and compliance. We break down its structure, Device Identifier (UDI-DI), Production Identifier (UDI-PI) and its role in EUDAMED.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  57. A hospital room full of equipment with futuristic user interfaces.

    IMDRF Sets the Standard: 10 Key Principles for AI-enabled Medical Devices

    Good Machine Learning Practice (GMLP) principles ensure safe devices, covering intended use, clinical evaluation & Human-AI Interaction (HAII).

    Ron Sangal Ron Sangal Lead Medical Writer
  58. A medical team discuss performance data at their desktop computer.

    Key Updates for Navigating EMDN: MDCG 2024-2 Rev.1 & 2021-12 Rev.1

    Release of the updated guidance helps manufacturers navigate the EMDN system for accurate device classification, ensuring market access.

    Ron Sangal Ron Sangal Lead Medical Writer
  59. A dated monitor for medical equipment.

    Understanding Clinical Evidence Requirements with MDCG 2020-6

    How can manufacturers ensure legacy devices meet MDR's stringent requirements? Discover how MDCG 2020-6 guidance simplifies the path to compliance.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  60. A stethoscope laid on a desk of regulatory documentation.

    Clinical benefits of an in vitro diagnostic medical device

    How to determine the clinical benefit of an IVD and successfully incorporate it into regulatory documentation.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  61. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson PhD Shona Richardson PhD Regulatory Project Lead
  62. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  63. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  64. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  65. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  66. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  67. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Regulatory Project Lead
  68. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  69. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  70. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  71. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  72. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Paul Hercock Paul Hercock CEO & Founder
  73. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  74. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Paul Hercock Paul Hercock CEO & Founder
  75. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  76. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  77. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  78. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Victoria Cartwright Victoria Cartwright Relationship Manager
  79. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Paul Hercock Paul Hercock CEO & Founder
  80. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  81. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Paul Hercock Paul Hercock CEO & Founder
  82. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Paul Hercock Paul Hercock CEO & Founder
  83. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Paul Hercock Paul Hercock CEO & Founder
  84. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Paul Hercock Paul Hercock CEO & Founder
  85. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Paul Hercock Paul Hercock CEO & Founder
  86. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Paul Hercock Paul Hercock CEO & Founder
  87. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Victoria Cartwright Victoria Cartwright Relationship Manager
  88. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Paul Hercock Paul Hercock CEO & Founder
  89. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Paul Hercock Paul Hercock CEO & Founder
  90. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Paul Hercock Paul Hercock CEO & Founder
  91. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Paul Hercock Paul Hercock CEO & Founder
  92. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Paul Hercock Paul Hercock CEO & Founder

More articles

Need help producing compliant CEPs & CERs? We are offering FREE CEPs to 5 qualifying applicants per week

Get your free CEP